Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery (AID) in adults with insulin-treated type 2 diabetes. AID significantly ...
In 2024, Insulet shared results from its landmark SECURE-T2D pivotal trial, demonstrating improved glycemic outcomes with Omnipod 5 compared with prior insulin injection or pump therapy in adults with ...
Omnipod 5 is the first AID system cleared for type 1 and type 2 diabetes management. Insulet’s Omnipod ® 5 Automated Insulin Delivery (AID) System has been cleared by the Food and Drug Administration ...
After the initiation of an AID system, glycemic control improved and the effect persisted throughout the study period. (HealthDay News) — Initiation of an automated insulin delivery (AID) system ...
Tandem Diabetes Care has announced that the U.S. Food and Drug Administration (FDA) has cleared Control-IQ+ automated insulin delivery (AID) technology for use in pregnancy complicated by ...
MANCHESTER, N.H. and GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, and Senseonics Holdings, Inc. (NYSE ...
The FDA has cleared Tandem’s Control-IQ technology as the first ever AID specifically for use in pregnancies complicated by ...
Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point greater drop in HbA1c than controls. The AID group also spent 3.4 more hours per ...
TORONTO — Clinical trials have shown that many automated insulin delivery (AID) systems are safe and effective for nonpregnant patients with type 1 diabetes (T1D). They are associated with improved ...
Do-it-yourself (DIY) automated insulin delivery systems have gained rapid uptake, yielding self-reported improvements in glycemic control and quality of life for patients, but creating unique ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results